Company
Clinical Diagnostics
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
32
510(k), De Novo and PMA
Device trials
2
As lead sponsor, any status
Adverse event reports
706
Received Nov 1, 2025 to Nov 20, 2026
Recall records
354
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Clinical Diagnostics, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Clinical Diagnostics.
Latest FDA decisions
The 8 newest of 32 since 2015.
K254262 · Decided Sep 4, 2026 · 248 days after receipt
Device type: Devices Detecting Influenza A, B, And C Virus Antigens (PSZ) · Laboratory Medicine & Pathology
K254264 · Decided Sep 4, 2026 · 248 days after receipt
Device type: Simple Point-Of-Care Device To Directly Detect Sars-Cov-2 Viral Targets From Clinical Specimens In Near-Patient Settings (QVF) · Laboratory Medicine & Pathology
K254295 · Decided Jul 10, 2026 · 191 days after receipt
Device type: Reagent, Borrelia Serological Reagent (LSR) · Laboratory Medicine & Pathology
29 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- Feasibility of a Lateral Flow Urine LAM Test for Diagnosis of Tuberculosis in South AfricaStatus unknown
NCT01693224 · 512 participants · Start Apr 2011 · Primary completion Feb 2013
Device: Alere "Determine" lateral-flow urine lipoarabinomannan assay; Alere "Clearview" ELISA urine LAM assay and 1 more · For: Tuberculosis; Tuberculosis, Pulmonary; Tuberculosis, Miliary
Sites: Cape Town, South Africa · 2 sites in all
- Feasibility of a Lateral Flow Urine Lipoarabinomannan (LAM) Test for Diagnosis of TuberculosisStatus unknown
NCT01525134 · 504 participants · Start Jan 2011 · Primary completion Feb 2012
Device: Alere "Determine" lateral-flow urine lipoarabinomannan assay; Alere "Clearview" ELISA urine LAM assay · For: Tuberculosis; Tuberculosis, Pulmonary; Tuberculosis, Miliary
Sites: Kampala, Uganda · 2 sites in all
Reports received
706
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
700
99% of reports
Injury reports
6
0.8% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 32 | 1 | 0 | 0 |
| Jan 24 | 35 | 0 | 0 | 0 |
| Feb 24 | 59 | 1 | 0 | 0 |
| Mar 24 | 45 | 1 | 0 | 0 |
| Apr 24 | 46 | 0 | 0 | 0 |
| May 24 | 24 | 1 | 0 | 0 |
| Jun 24 | 26 | 0 | 0 | 0 |
| Jul 24 | 52 | 0 | 0 | 0 |
| Aug 24 | 145 | 1 | 0 | 0 |
| Sep 24 | 108 | 0 | 0 | 0 |
| Oct 24 | 253 | 5 | 0 | 0 |
| Nov 24 | 179 | 2 | 0 | 0 |
| Dec 24 | 135 | 3 | 0 | 0 |
| Jan 25 | 123 | 3 | 0 | 0 |
| Feb 25 | 91 | 2 | 0 | 0 |
| Mar 25 | 79 | 0 | 0 | 0 |
| Apr 25 | 225 | 1 | 0 | 0 |
| May 25 | 49 | 0 | 0 | 0 |
| Jun 25 | 40 | 0 | 0 | 0 |
| Jul 25 | 40 | 0 | 0 | 0 |
| Aug 25 | 107 | 2 | 0 | 0 |
| Sep 25 | 57 | 1 | 0 | 0 |
| Oct 25 | 38 | 2 | 0 | 0 |
| Nov 25 | 72 | 0 | 0 | 0 |
| Dec 25 | 45 | 1 | 0 | 0 |
| Jan 26 | 58 | 0 | 0 | 0 |
| Feb 26 | 60 | 2 | 0 | 0 |
| Mar 26 | 76 | 0 | 0 | 0 |
| Apr 26 | 81 | 0 | 0 | 0 |
| May 26 | 38 | 1 | 0 | 0 |
| Jun 26 | 67 | 1 | 0 | 0 |
| Jul 26 | 56 | 0 | 0 | 0 |
| Aug 26 | 43 | 0 | 0 | 0 |
| Sep 26 | 65 | 1 | 0 | 0 |
| Oct 26 | 39 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Chemistry Products LAC Slides. Catalog Number: 8433880. 1 Sales Unit = contains 5 cartridges of 60 slides, for a total of 300 tests.Open, Classified
Z-2559-2025 · Started Jul 29, 2025 · Posted by FDA Sep 12, 2025
Reason given: VITROS Chemistry Products LAC Slides on VITROS XT 3400 and VITROS XT 7600 Systems are experiencing an increased occurrence of calibration failure related to lots from coating 0130 and above with Condition Code TH4-63J during calibration, causing the delay of lac test results and potentially impact patient management....
Cause as FDA categorized it: Device Design · Device type: Acid, Lactic, Enzymatic Method (KHP)
- VITROS Chemistry Products LAC Slides. Catalog Number: 8150112. 1 Sales Unit = contains 5 cartridges of 18 slides, for a total of 90 tests.Open, Classified
Z-2560-2025 · Started Jul 29, 2025 · Posted by FDA Sep 12, 2025
Reason given: VITROS Chemistry Products LAC Slides on VITROS XT 3400 and VITROS XT 7600 Systems are experiencing an increased occurrence of calibration failure related to lots from coating 0130 and above with Condition Code TH4-63J during calibration, causing the delay of lac test results and potentially impact patient management....
Cause as FDA categorized it: Device Design · Device type: Acid, Lactic, Enzymatic Method (KHP)
- VITROS Chemistry Products Ca Slides; Catalog Number: 145 0261;Open, Classified
Z-2335-2025 · Started Jul 9, 2025 · Posted by FDA Aug 15, 2025
Reason given: Generations 67 and above of VITROS Ca Slides are experiencing an increased occurrence of Condition Code TH4-63J during calibration on VITROS XT 3400 and VITROS XT 7600 Systems, causing calibration failures that delay calcium test results and potentially impact patient management. The imaging reflectometer algorithm...
Cause as FDA categorized it: Under Investigation by firm · Device type: Azo Dye, Calcium (CJY)
351 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.